Autopsy report · NCT00350766

Cell Therapy in Myocardial Infarction

“Slow recruitment rate and consequent financial exhaustion.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 8 years before it stopped.
• 166 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Ministry of Health, Brazil

Sponsor type

Government (non-US federal)

Conditions

Acute Myocardial Infarction

Interventions

Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation

Participants

166

Sites

1

Countries

Brazil

Trials that died the same way

• Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
  “Slow recruitment and inability to extend funding.” (79% match in meaning)
• BicepsTenodesis vs. Biceps Debridement in Combined RC Tears and SLAP Lesions
  “Due to low recruitment rate” (79% match in meaning)
• NHFOV Versus NCPAP to Prevent Exubation Failure
  “Poor recruitment rate” (78% match in meaning)
• Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
  “Slow pace of recruitment” (78% match in meaning)
• Management of Angiotensin Inhibitors During the Perioperative Period
  “slow recruitment rate” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.